Insulin-like growth factor binding protein-2 as a regulator of IGF actions in CNS: Implications in multiple sclerosis

Cytokine and Growth Factor Reviews

Volumn 18, Issue 3-4, 2007, Pages 267-278

  Chesik, Daniel ^a   De Keyser, Jacques ^a   Wilczak, Nadine ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Central nervous system; Demyelination; Insulin like growth factor; Insulin like growth factor binding protein 2; Multiple sclerosis

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2;

DEGENERATIVE DISEASE; DEMYELINATING DISEASE; MULTIPLE SCLEROSIS; MYELINATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM NEOPLASMS; DEMYELINATING DISEASES; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR I; LIGANDS; MODELS, BIOLOGICAL; MULTIPLE SCLEROSIS;

EID: 34249998175     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2007.04.001     Document Type: Short Survey

References (89)

1. Firth S.M., and Baxter R.C. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23 (2002) 824-854
2. Rajaram S., Baylink D.J., and Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr Rev 18 (1997) 801-831
3. Russo V.C., Gluckman P.D., Feldman E.L., and Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocr Rev 26 (2005) 916-943
4. Anlar B., Sullivan K.A., and Feldman E.L. Insulin-like growth factor-I and central nervous system development. Horm Metab Res 31 (1999) 120-125
5. Trejo J.L., Carro E., Lopez-Lopez C., and Torres-Aleman I. Role of serum insulin-like growth factor I in mammalian brain aging. Growth Horm IGF Res 14 (2004) 39-43
6. van Dam P.S., and Aleman A. Insulin-like growth factor-I, cognition and brain aging. Eur J Pharmacol 490 (2004) 87-95
7. Goddard D.R., Berry M., and Butt A.M. In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system. J Neurosci Res 57 (1999) 74-85
8. Collett-Solberg P.F., and Cohen P. The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 25 (1996) 591-614
9. Lee W.-H., Javedan S., and Bondy C.A. Coordinate expression of insulin-like growth factor system components by neurons and neuroglia during retinal and cerebellar development. J Neurosci 12 (1992) 4737-4744
10. Logan A., Gonzalez A.M., Hill D.J., Berry M., Gregson N.A., and Baird A. Coordinated pattern of expression and localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 in the adult rat brain. Endocrinology 135 (1994) 2255-2264
11. Bichell D.P., Kikuchi K., and Rotwein P. Growth hormone rapidly activates insulin-like growth factor I gene transcription in vivo. Mol Endocrinol 6 (1992) 1899-1908
12. Underwood L.E., Thissen J.P., Lemozy S., Ketelslegers J.M., and Clemmons D.R. Hormonal and nutritional regulation of IGF-I and its binding proteins. Horm Res 42 (1994) 145-151
13. Aberg N.D., Brywe K.G., and Isgaard J. Aspects of growth hormone and insulin-like growth factor-I related to neuroprotection, regeneration, and functional plasticity in the adult brain. Scientific World J 6 (2006) 53-80
14. Rotwein P., Burgess S.K., Milbrandt J.D., and Krause J.E. Differential expression of insulin-like growth factor genes in rat central nervous system. Proc Natl Acad Sci USA 85 (1988) 265-269
15. Bondy C., Werner H., Roberts Jr. C.T., and LeRoith D. Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II. Neuroscience 46 (1992) 909-923
16. Samani A.A., Yakar S., LeRoith D., and Brodt P. The role of the IGF system in cancer growth and metastasis: overview and recent insights. Endocr Rev 28 (2007) 20-47
17. Morgan D.O., Edman J.C., Standring D.N., Fried V.A., Smith M.C., Roth R.A., et al. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature 329 (1987) 301-307
18. Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 61 (1992) 307-330
19. Kooijman R. Regulation of apoptosis by insulin-like growth factor (IGF)-I. Cytokine Growth Factor Rev 17 (2006) 305-323
20. Feldman E.L., Sullivan K.A., Kim B., and Russell J.W. Insulin-like growth factors regulate neuronal differentiation and survival. Neurobiol Dis 4 (1997) 201-214
21. Sitar T., Popowicz G.M., Siwanowicz I., Huber R., and Holak T.A. Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc Natl Acad Sci USA 103 (2006) 13028-13033
22. Jones J.I., and Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 16 (1995) 3-34
23. Fowlkes J.L., and Serra D.M. Characterization of glycosaminoglycan-binding domains present in insulin-like growth factor-binding protein-3. J Biol Chem 271 (1996) 14676-14679
24. Jones J.I., Gockerman A., Busby Jr. W.H., Wright G., and Clemmons D.R. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA 90 (1993) 10553-10557
25. McCusker R.H., Camacho-Hubner C., Bayne M.L., Cascieri M.A., and Clemmons D.R. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs). J Cell Physiol 144 (1990) 244-253
26. Maile L.A., and Holly J.M. Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation. Growth Horm IGF Res 9 (1999) 85-95
27. Schneider M.R., Lahm H., Wu M., Hoeflich A., and Wolf E. Transgenic mouse models for studying the functions of insulin-like growth factor-binding proteins. FASEB J 14 (2000) 629-640
28. Mohan S., and Baylink D.J. IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175 (2002) 19-31
29. Wang G.K., Hu L., Fuller G.N., and Zhang W. An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility. J Biol Chem 281 (2006) 14085-14091
30. Badinga L., Song S., Simmen R.C., Clarke J.B., Clemmons D.R., and Simmen F.A. Complex mediation of uterine endometrial epithelial cell growth by insulin-like growth factor-II (IGF-II) and IGF-binding protein-2. J Mol Endocrinol 23 (1999) 277-285
31. Slootweg M.C., Ohlsson C., Salles J.P., de Vries C.P., and Netelenbos J.C. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Endocrinology 136 (1995) 4210-4217
32. Valentinis B., Bhala A., DeAngelis T., Baserga R., and Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9 (1995) 361-367
33. Cohen P., Rajah R., Rosenbloom J., and Herrick D.J. IGFBP-3 mediates TGF-beta1-induced cell growth in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 278 (2000) L545-L551
34. Schedlich L.J., Young T.F., Firth S.M., and Baxter R.C. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem 273 (1998) 18347-18352
35. Chesik D., Wilczak N., and De Keyser J. Insulin-like growth factor binding protein-4 interacts with centrosomes and microtubules in primary astrocytes. Neuroscience 125 (2004) 381-390
36. Spagnoli A., and Rosenfeld R.G. Insulin-like growth factor binding proteins. Curr Opin Endocrinol Diabet 4 (1997) 1-9
37. Yakar S., Domene H., Meidan R., Cassorla F., Gilad I., Koch I., et al. Growth hormone (GH) stimulates insulin-like growth factor-I (IGF-I) and IGF-binding protein (IGFBP)-2 gene expression in spleens of juvenile rats. Horm Metab Res 26 (1994) 363-366
38. Hoeflich A., Reisinger R., Lahm H., Kiess W., Blum W.F., Kolb H.J., et al. Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?. Cancer Res 61 (2001) 8601-8610
39. Hoeflich A., Wu M., Mohan S., Foll J., Wanke R., Froehlich T., et al. Overexpression of insulin-like growth factor-binding protein-2 in transgenic mice reduces postnatal body weight gain. Endocrinology 140 (1999) 5488-5496
40. Wood T.L., Rogler L.E., Czick M.E., Schuller A.G., and Pintar J.E. Selective alterations in organ sizes in mice with a targeted disruption of the insulin-like growth factor binding protein-2 gene. Mol Endocrinol 14 (2000) 1472-1482
41. Russo V.C., Bach L.A., and Werther G.A. Cell membrane association of insulin-like growth factor binding protein-2 (IGFBP-2) in the rat brain olfactory bulb. Prog Growth Factor Res 6 (1995) 329-336
42. Russo V.C., Bach L.A., Fosang A.J., Baker N.L., and Werther G.A. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology 138 (1997) 4858-4867
43. Conover C.A., and Khosla S. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. Growth Horm IGF Res 13 (2003) 328-335
44. Arai T., and Busby Jr. W. Clemmons DR. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology 137 (1996) 4571-4575
45. Russo V.C., Rekaris G., Baker N.L., Bach L.A., and Werther G.A. Basic fibroblast growth factor induces proteolysis of secreted and cell membrane-associated insulin-like growth factor binding protein-2 in human neuroblastoma cells. Endocrinology 140 (1999) 3082-3090
46. Frommer K.W., Reichenmiller K., Schutt B.S., Hoeflich A., Ranke M.B., Dodt G., et al. IGF-independent effects of IGFBP-2 on the human breast cancer cell line Hs578T. J Mol Endocrinol 37 (2006) 13-23
47. Pereira J.J., Meyer T., Docherty S.E., Reid H.H., Marshall J., Thompson E.W., et al. Bimolecular interaction of insulin-like growth factor (IGF) binding protein-2 with alphavbeta3 negatively modulates IGF-I-mediated migration and tumor growth. Cancer Res 64 (2004) 977-984
48. Russo V.C., Schutt B.S., Andaloro E., Ymer S.I., Hoeflich A., Ranke M.B., et al. Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. Endocrinology 146 (2005) 4445-4455
49. Hoeflich A., Reisinger R., Schuett B.S., Elmlinger M.W., Russo V.C., Vargas G.A., et al. Peri/nuclear localization of intact insulin-like growth factor binding protein-2 and a distinct carboxyl-terminal IGFBP-2 fragment in vivo. Biochem Biophys Res Commun 324 (2004) 705-710
50. Sullivan K.A., and Feldman E.L. Immunohistochemical localization of insulin-like growth factor-II (IGF-II) and IGF-binding protein-2 during development in the rat brain. Endocrinology 135 (1994) 540-547
51. Hwa V., Oh Y., and Rosenfeld R.G. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 20 (1999) 761-787
52. Tseng L.Y., Brown A.L., Yang Y.W., Romanus J.A., Orlowski C.C., Taylor T., et al. The fetal rat binding protein for insulin-like growth factors is expressed in the choroid plexus and cerebrospinal fluid of adult rats. Mol Endocrinol 3 (1989) 1559-1568
53. Chowen J.A., Goya L., Ramos S., Busiguina S., Garcia-Segura L.M., Argente J., et al. Effects of early undernutrition on the brain insulin-like growth factor-I system. J Neuroendocrinol 14 (2002) 163-169
54. Baker N.L., Russo V.C., Bernard O., D'Ercole A.J., and Werther G.A. Interactions between bcl-2 and the IGF system control apoptosis in the developing mouse brain. Brain Res Dev Brain Res 118 (1999) 109-118
55. Stylianopoulou F., Herbert J., Soares M.B., and Efstratiadis A. Expression of the insulin-like growth factor II gene in the choroid plexus and the leptomeninges of the adult rat central nervous system. Proc Natl Acad Sci USA 85 (1988) 141-145
56. Walter H.J., Berry M., Hill D.J., Cwyfan-Hughes S., Holly J.M., and Logan A. Distinct sites of insulin-like growth factor (IGF)-II expression and localization in lesioned rat brain: possible roles of IGF binding proteins (IGFBPs) in the mediation of IGF-II activity. Endocrinology 140 (1999) 520-532
57. Wolf E., Kramer R., Blum W.F., Foll J., and Brem G. Consequences of postnatally elevated insulin-like growth factor-II in transgenic mice: endocrine changes and effects on body and organ growth. Endocrinology 135 (1994) 1877-1886
58. Li W., Trovero F., Cordier J., Wang Y., Drieu K., and Papadopoulos V. Prenatal exposure of rats to Ginkgo biloba extract (EGb 761) increases neuronal survival/growth and alters gene expression in the developing fetal hippocampus. Brain Res Dev Brain Res 144 (2003) 169-180
59. Reijnders C.M., Koster J.G., and van Buul-Offers S.C. Overexpression of human IGF-II mRNA in the brain of transgenic mice modulates IGFBP-2 gene expression in the medulla oblongata. J Endocrinol 182 (2004) 445-455
60. Ye P., Popken G.J., Kemper A., McCarthy K., Popko B., and D'Ercole A.J. Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression. J Neurosci Res 78 (2004) 472-484
61. Kuhl N.M., De Keyser J., De Vries H., and Hoekstra D. Insulin-like growth factor binding proteins-1 and -2 differentially inhibit rat oligodendrocyte precursor cell survival and differentiation in vitro. J Neurosci Res 69 (2002) 207-216
62. Yao D.L., Liu X., Hudson L.D., and Webster H.D. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci USA 92 (1995) 6190-6194
63. Chesik D., Kuhl N.M., Wilczak N., and De Keyser J. Enhanced production and proteolytic degradation of insulin-like growth factor binding protein-2 in proliferating rat astrocytes. J Neurosci Res 77 (2004) 354-362
64. Chesik D., De Keyser J., Glazenburg L., and Wilczak N. Insulin-like growth factor binding proteins: regulation in chronic active plaques in multiple sclerosis and functional analysis of glial cells. Eur J Neurosci 24 (2006) 1645-1652
65. Wolf E., Lahm H., Wu M., Wanke R., and Hoeflich A. Effects of IGFBP-2 overexpression in vitro and in vivo. Pediatr Nephrol 14 (2000) 572-578
66. Walter H.J., Berry M., Hill D.J., and Logan A. Spatial and temporal changes in the insulin-like growth factor (IGF) axis indicate autocrine/paracrine actions of IGF-I within wounds of the rat brain. Endocrinology 138 (1997) 3024-3034
67. Breese C.R., D'Costa A., Rollins Y.D., Adams C., Booze R.M., Sonntag W.E., et al. Expression of insulin-like growth factor-1 (IGF-1) and IGF-binding protein 2 (IGF-BP2) in the hippocampus following cytotoxic lesion of the dentate gyrus. J Comp Neurol 369 (1996) 388-404
68. Sandberg Nordqvist A.C., von Holst H., Holmin S., Sara V.R., Bellander B.M., and Schalling M. Increase of insulin-like growth factor (IGF)-1, IGF binding protein-2 and -4 mRNAs following cerebral contusion. Brain Res Mol Brain Res 38 (1996) 285-293
69. Gehrmann J., Yao D.L., Bonetti B., Bondy C.A., Brenner M., Zhou J., et al. Expression of insulin-like growth factor-I and related peptides during motoneuron regeneration. Exp Neurol 128 (1994) 202-210
70. Beilharz E.J., Russo V.C., Butler G., Baker N.L., Connor B., Sirimanne E.S.A., Gluckman P.D., et al. Co-ordinated and cellular specific induction of the components of the IGF/IGFBP axis in the rat brain following hypoxic-ischemic injury. Brain Res Mol Brain Res 59 (1998) 119-134
71. Lee W.-H., Clemens J.A., and Bondy C.A. Insulin-like growth factors in response to cerebral ischemia. Mol Cell Neurosci 3 (1992) 36-43
72. Boulle N., Baudin E., Gicquel C., Logie A., Bertherat J., Penfornis A., et al. Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors. Eur J Endocrinol 144 (2001) 29-36
73. Muller H.L., Oh Y., Lehrnbecher T., Blum W.F., and Rosenfeld R.G. Insulin-like growth factor-binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab 79 (1994) 428-434
74. Elmlinger M.W., Deininger M.H., Schuett B.S., Meyermann R., Duffner F., Grote E.H., et al. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade. Endocrinology 142 (2001) 1652-1658
75. Wang H., Wang H., Shen W., Huang H., Hu L., et al. Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Cancer Res 63 (2003) 4315-4321
76. Liu X., Yao D.L., and Webster H. Insulin-like growth factor I treatment reduces clinical deficits and lesion severity in acute demyelinating experimental autoimmune encephalomyelitis. Mult Scler 1 (1995) 2-9
77. Liu X., Yao D.L., Bondy C.A., Brenner M., Hudson L.D., Zhou J., et al. Astrocytes express insulin-like growth factor-I (IGF-I) and its binding protein, IGFBP-2, during demyelination induced by experimental autoimmune encephalomyelitis. Mol Cell Neurosci 5 (1994) 418-430
78. Chesik D, Wilczak N, De Keyser J. The insulin-like growth factor system in multiple sclerosis. Int Rev Neurobiol, in press.
79. Torres-Aleman I., Barrios V., and Berciano J. The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis. Neurology 50 (1998) 772-776
80. Wilczak N., Schaaf M., Bredewold R., Streefland C., Teelken A., and De Keyser J. Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis. Neurosci Lett 257 (1998) 168-170
81. Poljakovic Z., Zurak N., Brinar V., Korsic M., Basic S., and Hajnsek S. Growth hormone and insulin growth factor-I levels in plasma and cerebrospinal fluid of patients with multiple sclerosis. Clin Neurol Neurosurg 108 (2006) 255-258
82. Gveric D., Cuzner M.L., and Newcombe J. Insulin-like growth factors and binding proteins in multiple sclerosis plaques. Neuropathol Appl Neurobiol 25 (1999) 215-225
83. Wilczak N., and De Keyser J. Insulin-like growth factor-I receptors in normal appearing white matter and chronic plaques in multiple sclerosis. Brain Res 772 (1997) 243-246
84. Wilczak N., De Bleser P., Luiten P., Geerts A., Teelken A., and De Keyser J. Insulin-like growth factor II receptors in human brain and their absence in astrogliotic plaques in multiple sclerosis. Brain Res 863 (2000) 282-288
85. Chesik D., De Keyser J., and Wilczak N. Involvement of insulin-like growth factor binding protein-2 in activated microglia as assessed in post mortem human brain. Neurosci Lett 362 (2004) 14-16
86. Conover C.A. Regulation of insulin-like growth factor (IGF)-binding protein synthesis by insulin and IGF-I in cultured bovine fibroblasts. Endocrinology 126 (1990) 3139-3145
87. Katz J., Weiss H., Goldman B., Kanety H., Stannard B., LeRoith D., et al. Cytokines and growth factors modulate cell growth and insulin-like growth factor binding protein secretion by the human salivary cell line (HSG). J Cell Physiol 165 (1995) 223-227
88. Streit W.J., Walter S.A., and Pennell N.A. Reactive microgliosis. Prog Neurobiol 57 (1999) 563-581
89. Werner H., Raizada M.K., Mudd L.M., Foyt H.L., Simpson I.A., Roberts Jr. C.T., et al. Regulation of rat brain/HepG2 glucose transporter gene expression by insulin and insulin-like growth factor-I in primary cultures of neuronal and glial cells. Endocrinology 125 (1989) 314-320